The Complete Guide to GLP-1 Weight Loss Medications
Compare medications, telehealth providers, and real costs. Evidence-based guidance for before, during, and after treatment.
Latest News
View all stories
Obesity Drug Trial Participants Abandon Studies After Identifying Placebo Treatment
Patients in obesity drug trials frequently recognize placebo treatments and withdraw from studies to seek effective GLP-1 medications, creating challenges for clinical trial validity.
GLP-1 Medications Drive Gym Members from Cardio to Weight Training
GLP-1 Drugs Cut Death Risk 28% in Diabetic Cancer Patients with Brain Metastases
FDA Approves Novo Nordisk's Awiqli as First Weekly Insulin for Type 2 Diabetes
Food Companies Market 'GLP-1 Friendly' Labels Without FDA Standards
GLP-1 Medications Reduce Depression Risk by 20% Independent of Weight Loss
Your Complete Treatment Journey
Comprehensive, independent guidance at every stage — from choosing the right medication to maintaining results long-term.
Drug Database & Decision Engine
Ozempic, Wegovy, Zepbound, Mounjaro — side-by-side comparison with clinical efficacy data, dosing schedules, and insurance coverage.
Explore the Drug DatabaseSide Effects & Provider Comparison
Real side effect profiles, telehealth provider comparison — Ro, Hims, Mochi, Found — with transparent cost breakdowns.
Read Side Effect GuidesOff-Ramp & Maintenance Guide
Evidence-based strategies for maintaining weight loss after stopping GLP-1 treatment, including tapering protocols.
Off-Ramp Strategies